Shawn Cross

Insider Reports History

Location
Washington, DC
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shawn Cross:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Chief Financial Officer Common Stock 56,250 $1,414,125 $25.14 10 Dec 2025 Direct
Cyclo Therapeutics, Inc. Director Common Stock 136,346 $85,898 $0.6300 27 Feb 2025 Direct
Pacira BioSciences, Inc. Chief Financial Officer Stock Option (Right to Buy) 175,000 10 Dec 2025 Direct
Cyclo Therapeutics, Inc. Director Stock Option (Right to Buy) 15,562 03 Jun 2024 Direct
Applied Molecular Transport Inc. CEO & Chair of the Board, Director Common Stock 0 $0.1634 27 Dec 2023 Direct
Applied Molecular Transport Inc. CEO & Chair of the Board, Director Stock Option (Right to Buy) 0 27 Dec 2023 Direct

Insider Reports Filed by Shawn Cross

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCRX Pacira BioSciences, Inc. 09 Dec 2025 6 -$215,501 4 Chief Financial Officer 11 Dec 2025, 21:47
PCRX Pacira BioSciences, Inc. 10 Nov 2025 1 -$266,405 4 Chief Financial Officer 13 Nov 2025, 16:13
PCRX Pacira BioSciences, Inc. 31 Oct 2025 1 -$143,032 4 Chief Financial Officer 03 Nov 2025, 17:41
CYTH Cyclo Therapeutics, Inc. 27 Feb 2025 1 $0 4 Director 03 Mar 2025, 11:44
CYTH Cyclo Therapeutics, Inc. 15 Nov 2024 1 $0 4 Director 18 Nov 2024, 14:10
PCRX Pacira BioSciences, Inc. 01 Nov 2024 2 $0 4 Chief Financial Officer 05 Nov 2024, 16:42
PCRX Pacira BioSciences, Inc. 21 Oct 2024 0 $0 3 Chief Financial Officer 23 Oct 2024, 18:54
CYTH Cyclo Therapeutics, Inc. 16 Aug 2024 1 $0 4 Director 20 Aug 2024, 13:49
CYTH Cyclo Therapeutics, Inc. 03 Jun 2024 2 $0 4 Director 05 Jun 2024, 17:09
CYTH Cyclo Therapeutics, Inc. 27 Dec 2023 2 $0 4 Director 28 Dec 2023, 21:50
CYTH Cyclo Therapeutics, Inc. 27 Dec 2023 0 $0 3 Director 28 Dec 2023, 21:48
/report/000120919123059929-cross-shawn-2023-12-27 Applied Molecular Transport Inc. 27 Dec 2023 6 $0 4 CEO & Chair of the Board, Director 28 Dec 2023, 17:29
/report/000120919123056587-cross-shawn-2023-11-22 Applied Molecular Transport Inc. 22 Nov 2023 1 -$18,116 4 CEO & Chair of the Board, Director 24 Nov 2023, 16:21
/report/000120919123055560-cross-shawn-2023-11-15 Applied Molecular Transport Inc. 15 Nov 2023 1 -$14,526 4 CEO & Chair of the Board, Director 16 Nov 2023, 17:36
/report/000120919123051217-cross-shawn-2023-09-28 Applied Molecular Transport Inc. 28 Sep 2023 2 -$30,743 4 CEO & Chair of the Board, Director 02 Oct 2023, 19:02
/report/000120919123052122-cross-shawn-2023-06-02 Applied Molecular Transport Inc. 02 Jun 2023 4 -$1,298 4 CEO & Chair of the Board, Director 04 Oct 2023, 19:27
/report/000120919123021327-cross-shawn-2023-03-24 Applied Molecular Transport Inc. 24 Mar 2023 1 $0 4 CEO & Chair of the Board, Director 27 Mar 2023, 21:11
/report/000120919123015778-cross-shawn-2023-03-01 Applied Molecular Transport Inc. 01 Mar 2023 1 -$467 4 President & COO 03 Mar 2023, 16:20
/report/000120919122060031-cross-shawn-2022-12-02 Applied Molecular Transport Inc. 02 Dec 2022 1 -$4,088 4 President & COO 06 Dec 2022, 15:56
/report/000120919122048870-cross-shawn-2022-09-01 Applied Molecular Transport Inc. 01 Sep 2022 2 -$1,255 4 President & COO 06 Sep 2022, 19:17
/report/000120919122034352-cross-shawn-2022-06-01 Applied Molecular Transport Inc. 01 Jun 2022 2 -$11,834 4 President & COO 03 Jun 2022, 19:20
/report/000120919122030208-cross-shawn-2022-05-16 Applied Molecular Transport Inc. 16 May 2022 2 $0 4 President & COO 18 May 2022, 18:07
/report/000120919122010366-cross-shawn-2022-02-15 Applied Molecular Transport Inc. 15 Feb 2022 2 $0 4 Chief Financial Officer 16 Feb 2022, 18:57
/report/000120919122002244-cross-shawn-2021-12-24 Applied Molecular Transport Inc. 24 Dec 2021 1 $0 4 Chief Financial Officer 06 Jan 2022, 18:22
/report/000156761921021518-cross-shawn-2021-12-02 BioPlus Acquisition Corp. 02 Dec 2021 0 $0 3 Director 02 Dec 2021, 18:44
/report/000120919121053042-cross-shawn-2021-08-19 Applied Molecular Transport Inc. 19 Aug 2021 6 -$255,093 4 Chief Financial Officer 23 Aug 2021, 19:40